Literature DB >> 3731112

Chromosomal changes without DNA overproduction in hydroxyurea-treated mammalian cells: implications for gene amplification.

P Hahn, L N Kapp, W F Morgan, R B Painter.   

Abstract

It has been reported that a 6-h incubation of early S-phase Chinese hamster cells with hydroxyurea promotes DNA overproduction, i.e., replication of DNA a second time within a single cell cycle, and that this could be the basis for gene amplification in drug-treated mammalian cells. When we incubated methotrexate-resistant Chinese hamster cells that were approximately 2 h into the S phase with hydroxyurea for 6 h, DNA that had been replicated before the incubation with hydroxyurea (early S-phase DNA) was replicated again within 11 h after the hydroxyurea treatment. However, incubation with colchicine or Colcemid after hydroxyurea treatment virtually abolished this overreplication, as well as that of the amplified dihydrofolate reductase genes in these cells, indicating that the second replication had occurred in a second cell cycle. Cells collected in the first mitosis after incubation with hydroxyurea never contained overreplicated DNA but did contain abundant chromosome aberrations. Early S-phase DNA replicated again on schedule during the first few hours after mitosis. Asymmetric segregation of chromosome fragments or unequal sister chromatid exchange may be the actual basis for gene amplification in drug-treated mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731112

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Clonal dynamics of progressive neoplastic transformation.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas.

Authors:  Nicolas Vogt; Sandrine-Hélène Lefèvre; Françoise Apiou; Anne-Marie Dutrillaux; Andrej Cör; Pascal Leuraud; Marie-France Poupon; Bernard Dutrillaux; Michelle Debatisse; Bernard Malfoy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

3.  Autonomously replicating episomes contain mdr1 genes in a multidrug-resistant human cell line.

Authors:  J C Ruiz; K H Choi; D D von Hoff; I B Roninson; G M Wahl
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

Review 4.  Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.

Authors:  L P Villarreal
Journal:  Microbiol Rev       Date:  1991-09

5.  A cytogenetic investigation of DNA rereplication after hydroxyurea treatment: implications for gene amplification.

Authors:  W F Morgan; J Bodycote; M L Fero; P J Hahn; L N Kapp; G E Pantelias; R B Painter
Journal:  Chromosoma       Date:  1986       Impact factor: 4.316

6.  Double minute chromosomes can be produced from precursors derived from a chromosomal deletion.

Authors:  S M Carroll; M L DeRose; P Gaudray; C M Moore; D R Needham-Vandevanter; D D Von Hoff; G M Wahl
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

7.  A critical test of the role of population density in producing transformation.

Authors:  A Yao; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

8.  Induction of circles of heterogeneous sizes in carcinogen-treated cells: two-dimensional gel analysis of circular DNA molecules.

Authors:  S Cohen; S Lavi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

9.  Ubiquitous, heritable damage in cell populations that survive treatment with methotrexate.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

10.  Hairpin structures are the primary amplification products: a novel mechanism for generation of inverted repeats during gene amplification.

Authors:  S Cohen; D Hassin; S Karby; S Lavi
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.